REGENERON PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
REGENERON PHARMACEUTICALS, INC. (REGN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $517.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $319.10M, a 38.32% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $198.60M, a 10.64% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$82.80M, a 249.73% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $47.90M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $375.30M, a 7.90% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $407.50M, a 239.30% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $120.10M, a 19.18% decline from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $148.60M, a 38.26% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $319.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $517.70M 10-Q · filed 2026-07-30 | $434.90M derived: sum of 3 quarters · filed 2026-07-30 | $482.80M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $198.60M 10-Q · filed 2026-04-29 | $115.80M derived: sum of 2 quarters · filed 2026-04-29 | $163.70M derived: sum of 3 quarters · filed 2026-04-29 | $394.40M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$82.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | -$34.90M derived: sum of 2 quarters · filed 2026-02-04 | $195.80M derived: sum of 3 quarters · filed 2026-07-30 | $375.30M 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $47.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $278.60M derived: sum of 2 quarters · filed 2026-07-30 | $458.10M 10-Q · filed 2025-10-28 | $513.40M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $230.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $410.20M 10-Q · filed 2026-07-30 | $465.50M derived: sum of 3 quarters · filed 2026-07-30 | $213.50M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $179.50M 10-Q · filed 2026-04-29 | $234.80M derived: sum of 2 quarters · filed 2026-04-29 | -$17.20M derived: sum of 3 quarters · filed 2026-04-29 | $509.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $55.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | -$196.70M derived: sum of 2 quarters · filed 2026-02-04 | $329.60M derived: sum of 3 quarters · filed 2026-02-04 | $407.50M 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | -$252.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $274.30M derived: sum of 2 quarters · filed 2025-10-28 | $352.20M 10-Q · filed 2025-10-28 | $187.90M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $526.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $604.20M 10-Q · filed 2025-08-01 | $439.90M derived: sum of 3 quarters · filed 2026-02-04 | $715.40M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | $77.90M 10-Q · filed 2025-04-29 | -$86.40M derived: sum of 2 quarters · filed 2026-02-04 | $189.10M derived: sum of 3 quarters · filed 2026-02-04 | $192.50M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | -$164.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $111.20M derived: sum of 2 quarters · filed 2026-02-04 | $114.60M derived: sum of 3 quarters · filed 2026-02-04 | $120.10M 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $275.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $278.90M derived: sum of 2 quarters · filed 2024-10-31 | $284.40M 10-Q · filed 2024-10-31 | $265.70M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $8.90M 10-Q · filed 2024-08-01 | -$9.80M derived: sum of 3 quarters · filed 2025-02-05 | -$131.00M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | $5.50M 10-Q · filed 2024-05-02 | -$13.20M derived: sum of 2 quarters · filed 2025-02-05 | -$134.40M derived: sum of 3 quarters · filed 2025-02-05 | $109.30M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | -$18.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | -$139.90M derived: sum of 2 quarters · filed 2025-02-05 | $103.80M derived: sum of 3 quarters · filed 2025-02-05 | $148.60M 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | -$121.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $122.50M derived: sum of 2 quarters · filed 2023-11-02 | $167.30M 10-Q · filed 2023-11-02 | $91.20M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | $243.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $288.50M 10-Q · filed 2023-08-03 | $212.40M derived: sum of 3 quarters · filed 2024-02-05 | $251.40M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | $44.80M 10-Q · filed 2023-05-04 | -$31.30M derived: sum of 2 quarters · filed 2024-02-05 | $7.70M derived: sum of 3 quarters · filed 2024-02-05 | $235.50M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | -$76.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | -$37.10M derived: sum of 2 quarters · filed 2024-02-05 | $190.70M derived: sum of 3 quarters · filed 2024-02-05 | $240.70M 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $266.80M derived: sum of 2 quarters · filed 2022-11-03 | $316.80M 10-Q · filed 2022-11-03 | $218.30M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | $227.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $277.80M 10-Q · filed 2022-08-03 | $179.30M derived: sum of 3 quarters · filed 2023-02-06 | $196.70M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | $50.00M 10-Q · filed 2022-05-04 | -$48.50M derived: sum of 2 quarters · filed 2023-02-06 | -$31.10M derived: sum of 3 quarters · filed 2023-02-06 | $5.20M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | -$98.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | -$81.10M derived: sum of 2 quarters · filed 2023-02-06 | -$44.80M derived: sum of 3 quarters · filed 2023-02-06 | -$114.90M 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $17.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $53.70M derived: sum of 2 quarters · filed 2021-11-04 | -$16.40M 10-Q · filed 2021-11-04 | $88.20M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | $36.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$33.80M 10-Q · filed 2021-08-05 | $70.80M derived: sum of 3 quarters · filed 2022-02-07 | $79.20M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | -$70.10M 10-Q · filed 2021-05-06 | $34.50M derived: sum of 2 quarters · filed 2022-02-07 | $42.90M derived: sum of 3 quarters · filed 2022-02-07 | $64.00M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $104.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $113.00M derived: sum of 2 quarters · filed 2022-02-07 | $134.10M derived: sum of 3 quarters · filed 2022-02-07 | $79.80M 10-K · filed 2022-02-07 | $130.40M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $29.50M derived: sum of 2 quarters · filed 2020-11-05 | -$24.80M 10-Q · filed 2020-11-05 | -$21.20M 10-Q · filed 2019-11-05 | -$24.50M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-06-30 | $21.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$33.20M 10-Q · filed 2020-08-05 | -$42.50M 10-Q · filed 2019-08-06 | -$32.90M derived: sum of 3 quarters · filed 2021-02-08 | $114.30M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-03-31 | -$54.30M 10-Q · filed 2020-05-05 | -$69.30M 10-Q · filed 2019-05-07 | -$54.00M derived: sum of 2 quarters · filed 2021-02-08 | $93.20M derived: sum of 3 quarters · filed 2021-02-08 | $102.60M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2018-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $147.50M derived: sum of 2 quarters · filed 2021-02-08 | $156.90M derived: sum of 3 quarters · filed 2021-02-08 | $88.10M 10-K · filed 2021-02-08 | $55.70M 10-K · filed 2019-02-07 | |||
| 2018-09-30 | $147.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $156.60M derived: sum of 2 quarters · filed 2019-11-05 | $87.80M 10-Q · filed 2019-11-05 | $87.82M 10-Q · filed 2018-11-06 | $172.89M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-06-30 | $9.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$59.40M 10-Q · filed 2019-08-06 | -$59.43M 10-Q · filed 2018-08-02 | $25.69M derived: sum of 3 quarters · filed 2020-02-07 | -$23.27M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-03-31 | -$68.80M 10-Q · filed 2019-05-07 | -$68.84M 10-Q · filed 2018-05-03 | $16.29M derived: sum of 2 quarters · filed 2020-02-07 | -$32.67M derived: sum of 3 quarters · filed 2020-02-07 | $24.18M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $85.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $36.13M derived: sum of 2 quarters · filed 2020-02-07 | $92.97M derived: sum of 3 quarters · filed 2020-02-07 | $113.30M 10-K · filed 2020-02-07 | $113.33M 10-K · filed 2018-02-08 | |||
| 2017-09-30 | -$48.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $7.88M derived: sum of 2 quarters · filed 2018-11-06 | $28.21M 10-Q · filed 2018-11-06 | $26.97M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $56.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $77.17M 10-Q · filed 2018-08-02 | $75.92M derived: sum of 3 quarters · filed 2019-02-07 | $98.15M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $20.32M 10-Q · filed 2018-05-03 | $19.08M derived: sum of 2 quarters · filed 2019-02-07 | $41.31M derived: sum of 3 quarters · filed 2019-02-07 | $23.48M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $20.99M derived: sum of 2 quarters · filed 2019-02-07 | $3.16M derived: sum of 3 quarters · filed 2019-02-07 | -$36.10M 10-K · filed 2019-02-07 | -$23.54M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | $22.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.40M derived: sum of 2 quarters · filed 2017-11-08 | -$34.86M 10-Q · filed 2017-11-08 | $31.40M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | -$17.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$57.09M 10-Q · filed 2017-08-03 | $9.17M derived: sum of 3 quarters · filed 2018-02-08 | $56.23M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | -$39.26M 10-Q · filed 2017-05-04 | $26.99M derived: sum of 2 quarters · filed 2018-02-08 | $74.06M derived: sum of 3 quarters · filed 2018-02-08 | $83.65M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $66.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $113.32M derived: sum of 2 quarters · filed 2018-02-08 | $122.91M derived: sum of 3 quarters · filed 2018-02-08 | $79.48M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $47.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $56.66M derived: sum of 2 quarters · filed 2016-11-04 | $13.22M 10-Q · filed 2016-11-04 | $29.70M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $9.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$33.84M 10-Q · filed 2016-08-04 | -$17.36M derived: sum of 3 quarters · filed 2017-02-09 | -$17.96M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | -$43.43M 10-Q · filed 2016-05-05 | -$35.87M 10-Q · filed 2015-05-07 | -$26.96M derived: sum of 2 quarters · filed 2017-02-09 | -$27.55M derived: sum of 3 quarters · filed 2017-02-09 | -$19.00M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2014-12-31 | $16.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $15.88M derived: sum of 2 quarters · filed 2017-02-09 | $24.43M derived: sum of 3 quarters · filed 2017-02-09 | $45.33M 10-K · filed 2017-02-09 | $37.77M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | -$596.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $7.95M derived: sum of 2 quarters · filed 2015-11-04 | $28.85M 10-Q · filed 2015-11-04 | $25.02M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $8.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $29.45M 10-Q · filed 2015-08-04 | $25.61M derived: sum of 3 quarters · filed 2016-02-11 | $24.57M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $20.90M 10-Q · filed 2015-05-07 | $17.07M derived: sum of 2 quarters · filed 2016-02-11 | $16.03M derived: sum of 3 quarters · filed 2016-02-11 | -$4.49M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | -$3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$4.87M derived: sum of 2 quarters · filed 2016-02-11 | -$25.39M derived: sum of 3 quarters · filed 2016-02-11 | -$7.57M 10-K · filed 2016-02-11 | $52.77M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$21.55M derived: sum of 2 quarters · filed 2014-11-04 | -$3.74M 10-Q · filed 2014-11-04 | $84.11M 10-Q · filed 2013-11-05 | -$49.61M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-06-30 | -$20.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$2.70M 10-Q · filed 2014-08-05 | $51.70M 10-Q · filed 2013-08-06 | -$48.57M derived: sum of 3 quarters · filed 2015-02-12 | $3.15M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-03-31 | $17.82M 10-Q · filed 2014-05-08 | $43.66M 10-Q · filed 2013-05-03 | -$28.06M derived: sum of 2 quarters · filed 2015-02-12 | $23.67M derived: sum of 3 quarters · filed 2015-02-12 | $36.52M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2012-12-31 | -$45.87M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $5.85M derived: sum of 2 quarters · filed 2015-02-12 | $18.71M derived: sum of 3 quarters · filed 2015-02-12 | $25.37M 10-K · filed 2015-02-12 | $52.62M 10-K · filed 2013-02-15 | |||
| 2012-09-30 | $51.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $64.58M derived: sum of 2 quarters · filed 2013-11-05 | $71.24M 10-Q · filed 2013-11-05 | $61.89M 10-Q · filed 2012-10-24 | $68.06M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-06-30 | $12.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $19.52M 10-Q · filed 2013-08-06 | $10.64M 10-Q · filed 2012-07-25 | $16.33M derived: sum of 3 quarters · filed 2014-02-13 | $14.43M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-03-31 | $6.66M 10-Q · filed 2013-05-03 | $4.49M 10-Q · filed 2012-04-26 | $3.47M derived: sum of 2 quarters · filed 2014-02-13 | $1.58M derived: sum of 3 quarters · filed 2014-02-13 | $11.61M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2011-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$5.08M derived: sum of 2 quarters · filed 2014-02-13 | $4.95M derived: sum of 3 quarters · filed 2014-02-13 | -$6.61M 10-K · filed 2014-02-13 | $6.03M 10-K · filed 2012-02-21 | |||
| 2011-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $8.13M derived: sum of 2 quarters · filed 2012-10-24 | -$3.42M 10-Q · filed 2012-10-24 | $6.31M 10-Q · filed 2011-10-27 | $8.23M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $10.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | -$1.53M 10-Q · filed 2012-07-25 | $8.16M 10-Q · filed 2011-07-28 | $10.13M derived: sum of 3 quarters · filed 2013-02-15 | $8.29M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | -$11.56M 10-Q · filed 2012-04-26 | -$2.29M 10-Q · filed 2011-05-03 | $99.00K derived: sum of 2 quarters · filed 2013-02-15 | -$1.74M derived: sum of 3 quarters · filed 2013-02-15 | -$5.83M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $9.82M derived: sum of 2 quarters · filed 2013-02-15 | $5.73M derived: sum of 3 quarters · filed 2013-02-15 | $8.21M 10-K · filed 2013-02-15 | -$2.72M 10-K · filed 2011-02-17 | |||
| 2010-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$5.93M derived: sum of 2 quarters · filed 2011-10-27 | -$3.45M 10-Q · filed 2011-10-27 | $620.00K derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | -$4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$1.60M 10-Q · filed 2011-07-28 | $2.46M derived: sum of 3 quarters · filed 2012-02-21 | $2.25M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $2.48M 10-Q · filed 2011-05-03 | $6.55M derived: sum of 2 quarters · filed 2012-02-21 | $6.34M derived: sum of 3 quarters · filed 2012-02-21 | |||||
| 2009-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $3.86M derived: sum of 2 quarters · filed 2012-02-21 | $4.44M 10-K · filed 2012-02-21 | $4.57M 10-K · filed 2011-02-17 | ||||
| 2009-09-30 | -$208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $370.00K 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $578.00K 10-Q · filed 2010-07-28 | |||||||
| 2008-12-31 | $6.56M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |